Therapeutic Goods Regulation In Australia: Comprehensive Compliance Guide

If you’re developing, importing or selling therapeutic goods in Australia, getting the regulatory side right from day one is essential. The Therapeutic Goods Administration (TGA) has strict rules about what can be supplied, how products are assessed, the claims you can make, and the quality systems you need behind the scenes.

The good news? With a clear roadmap, you can navigate the process confidently and build a compliant, scalable business. In this guide, we’ll break down how therapeutic goods are regulated in Australia, what approvals you may need, and the practical legal steps to launch and keep trading compliantly.

Whether you’re launching a medical device, complementary medicine, disinfectant, software as a medical device (SaMD), or another health-related product, this guide is designed to help you understand the pathway and avoid common pitfalls.

What Counts As A “Therapeutic Good” In Australia?

Therapeutic goods are products used in humans for preventing, diagnosing, curing or alleviating disease, injury or disability, or that influence, inhibit or modify a physiological process. This includes (but isn’t limited to):

• Prescription and over-the-counter medicines, vaccines and biologicals
• Complementary medicines (e.g. vitamins, herbal supplements, some probiotics)
• Medical devices (e.g. diagnostics, surgical tools, software as a medical device, wearables)
• Disinfectants and sterilants with therapeutic claims
• Some cosmetics if you make therapeutic claims (e.g. claims to treat a disease)

If a product makes a therapeutic claim, it is likely captured by the Therapeutic Goods Act 1989 and the Therapeutic Goods (Medical Devices) Regulations 2002 or related frameworks. Getting the classification right up front drives your entire compliance pathway.

Who Regulates Therapeutic Goods And How Does The System Work?

The TGA (within the Australian Government Department of Health and Aged Care) regulates therapeutic goods. Most products must be included in the Australian Register of Therapeutic Goods (ARTG) before you can supply them locally, unless a specific exemption applies (for example, clinical trials or certain lab-use-only products).

Key concepts to understand:

• Sponsor: The Australian entity legally responsible for the product in Australia (often the importer, manufacturer or brand owner). The sponsor submits the application to the ARTG and manages post-market obligations.
• ARTG inclusion: Depending on the product type and risk classification, goods are either Listed, Registered (medicines), or included as Medical Devices (including IVDs). Higher-risk goods undergo deeper pre-market assessment and evidence review.
• Conformity assessment and GMP: Devices must meet the Essential Principles and carry appropriate conformity assessment certification. Medicines must comply with Good Manufacturing Practice (GMP). Overseas evidence may be acceptable if it meets TGA requirements.
• Advertising and labelling rules: The Therapeutic Goods Advertising Code and related TGA guidance set strict requirements for consumer-facing claims, evidence, and mandatory statements.
• Scheduling: The Poisons Standard (SUSMP) determines availability controls (e.g. Pharmacy Only, Prescription Only) for certain substances. State and territory laws also apply for handling and supply.

Understanding your role (sponsor/manufacturer/importer), your product’s classification and the evidence pathway will help you plan timeframes and costs accurately.

Your Step-By-Step Roadmap To Compliance

1) Define The Product And Its Claims

Start by documenting what your product is, what it does, and the claims you plan to make. Your intended purpose and claims determine the product category (medicine vs device), its risk classification, and the evidence required.

2) Confirm The Regulatory Pathway And Classification

Map your product against TGA guidance to confirm its category and risk class. For medical devices, this involves applying the classification rules (Class I to III, AIMD; IVD categories). For medicines, decide if the product sits in a lower-risk Listed pathway (with permitted indications) or a higher-risk Registered pathway requiring full evaluation.

3) Appoint An Australian Sponsor

If you’re not already an Australian entity, appoint an Australian sponsor who will be legally responsible for ARTG inclusion, reporting adverse events, advertising compliance and recalls. Ensure roles are clear and documented in supply and distribution contracts.

4) Prepare Your Technical Dossier And Evidence

Collect clinical and/or non-clinical evidence that supports your claims, along with quality, safety and performance data. For devices, prepare a technical file addressing the Essential Principles and risk management (e.g. ISO 14971). For medicines, assemble quality, safety, efficacy data as required by the pathway.

5) Ensure Manufacturing Compliance (GMP/Conformity Assessment)

Confirm your manufacturer has appropriate certifications. Medicine manufacturers need GMP compliance recognised by the TGA. Device manufacturers need conformity assessment certification appropriate to the device class. If relying on overseas certificates, check TGA acceptability and whether additional audits are needed.

6) Apply For ARTG Inclusion

Submit your application (and fees) via TGA systems. Lower risk products may undergo automated or streamlined review, while higher-risk submissions will be evaluated in depth. Timeframes vary widely based on risk class and completeness of your dossier.

7) Finalise Labels, Instructions For Use (IFU) And Packaging

Labelling must meet TGA requirements (and, where relevant, UDI/device identifiers), include mandatory statements and be consistent with your approved indications and evidence. Ensure IFU are clear, accurate and accessible.

8) Secure Supply Chain And Commercial Contracts

Lock in terms with suppliers, manufacturers and wholesalers. A tailored Supply Agreement can set quality standards, delivery, pricing, liability and IP ownership clearly so you’re protected if things go wrong.

9) Configure Advertising And Promotional Materials

Review all marketing claims against the Therapeutic Goods Advertising Code and ensure evidence support. Pay special attention to consumer-facing copy, comparative claims, testimonials, influencer content and promotions.

10) Set Up A Post-Market Surveillance System

Establish procedures to capture complaints, adverse events and product quality issues. Sponsors must investigate, report certain events to the TGA, and execute corrective actions, including recalls if required.

Ongoing Compliance: What To Watch After Launch

Post-Market Monitoring And Vigilance

After launch, you must monitor product performance, update risk assessments, and act on safety signals. Ensure staff and distributors know how to spot and escalate quality issues quickly.

Recalls And Corrective Actions

Be prepared with a documented recall plan and roles. If a safety or quality issue emerges, sponsors must coordinate with the TGA to execute corrections, withdrawals or recalls efficiently and transparently.

Advertising And Consumer Law

Advertising must remain accurate, balanced and consistent with approved indications and the Code. Beyond TGA rules, claims and promotions must comply with the Australian Consumer Law (ACL), including the general prohibition on misleading or deceptive conduct under section 18.

If you provide written warranties or satisfaction guarantees, ensure they meet ACL and TGA requirements. A fit-for-purpose Warranties Against Defects Policy helps set expectations clearly and keeps your documents compliant.

Data And Privacy

If you collect personal information (including health data or device telemetry tied to individuals), you’ll need a transparent, tailored Privacy Policy that explains what you collect, why, how you use it and who you share it with. Make sure your practices align with what you say, especially around consent, access and deletion.

Given the sensitivity of health information, it’s prudent to maintain incident response procedures and consider a data breach playbook. If you experience a data incident, timelines are tight under the Notifiable Data Breaches scheme, so preparation is key.

Selling Online Or Direct-To-Consumer? Your Digital Compliance Checklist

Many therapeutic goods businesses sell online, whether B2B or D2C. In addition to TGA/ARTG compliance, make sure your digital foundations are solid:

• Website terms: Set the rules of use, permitted conduct, disclaimers and IP ownership through robust Website Terms and Conditions.
• Clear sales terms: Spell out pricing, shipping, returns and risk of loss in your online Terms of Sale. Align these with the ACL and your TGA obligations (e.g. no off-label claims).
• Privacy and cookies: Be transparent about tracking and analytics, and ensure your Privacy Policy reflects actual data flows (including any overseas processors).
• Claims discipline: Cross-check website copy, banners, FAQs and blogs against your approved claims and evidence. Apply the Advertising Code to social posts, influencer scripts and email marketing too.
• Customer support and complaints: Embed a simple pathway for customers to raise complaints and adverse events, and train your support team to triage issues appropriately.

What Legal Documents Will I Need?

Every business is different, but most therapeutic goods ventures benefit from the following core documents. Having them tailored to your model reduces risk and makes day-to-day operations smoother.

• Supply Agreement: Sets quality standards, delivery, pricing, forecasting, liability caps and IP ownership with your suppliers and contract manufacturers. Start with a strong Supply Agreement and adapt for each relationship.
• Manufacturing Agreement: Aligns GMP/compliance obligations, change control, audits, corrective actions and recall cooperation with manufacturers. (If you outsource manufacture, this is critical.)
• Distribution/Wholesale Terms: Governs territory, minimums, promotional conduct, claims discipline, returns and termination. Make sure distributors follow the Advertising Code and your brand rules.
• Website Terms And Conditions: Defines site use, IP rights, disclaimers and limits of liability for online users via your Website Terms and Conditions.
• Terms Of Sale: Covers ordering, delivery, returns, refunds and ACL compliance for online or retail transactions through your Terms of Sale.
• Privacy Policy: Explains the personal information you collect and how you handle it, especially for health data and connected devices, using a tailored Privacy Policy.
• Warranties/Guarantees: Sets warranty durations, what’s covered, and how customers claim, supported by a compliant Warranties Against Defects Policy.
• Quality/Compliance SOPs: Internal procedures for handling complaints, adverse events, field safety corrective actions, recalls and TGA reporting.
• IP And Brand Protection: Protect your brand name and logo by applying to register your trade mark, and align contracts so created IP is owned by your company.
• Employment And Contractor Agreements: If you’re hiring, use clear, compliant agreements and role-specific policies; for example, a tailored Employment Contract for staff in quality, regulatory and customer support.

Not every business needs every document on day one, but putting the core contracts in place early reduces disputes, speeds up audits and due diligence, and gives you confidence to scale.

Product-Specific Issues: Medicines, Devices And SaMD

Complementary Medicines

Most complementary medicines follow the Listed pathway with permitted indications and a self-certification process - but the TGA routinely audits to ensure evidence supports your claims. Keep literature and substantiation on file, and align labels and marketing.

Medical Devices (Including IVDs)

For devices, classification drives evidence and conformity assessment. You’ll need to address the Essential Principles, risk management, clinical evaluation (where applicable), and post-market surveillance. Ensure unique device identification (UDI) if applicable and up-to-date technical documentation for audits.

Software As A Medical Device (SaMD)

If your software diagnoses, prevents or manages disease, it’s likely a device. You’ll need secure development practices, validated algorithms, a quality management system, and a plan for updates and cybersecurity risk. Claims discipline and data governance are particularly important for SaMD.

Common Pitfalls (And How To Avoid Them)

• Unclear intended purpose: Vague claims can push your product into higher risk categories or cause advertising breaches. Define and stick to a clear intended purpose.
• Evidence gaps: Marketing moves faster than evidence. Don’t make claims you can’t substantiate to TGA and under ACL.
• Copy-paste labelling: Overseas labels rarely map perfectly to Australian rules. Localise labels and IFU carefully.
• Weak supplier terms: If quality slips or delivery fails, you carry the sponsor risk. Use robust supply and manufacturing contracts with enforceable quality obligations.
• Post-market blind spots: Set up simple processes to capture complaints, track trends and report early. Speed matters if safety issues arise.
• Digital claims drift: Website copy, blog posts and social media often stray beyond approved claims. Keep a single source of truth for approved wording.

Business Structure, IP And Team: Set Up To Scale

Beyond regulatory approvals, set your business up for long-term success:

• Structure: Choose a structure that suits your risk and growth plans (sole trader, partnership or company). Many health businesses opt for a company for liability separation and investor-readiness.
• Brand protection: Secure and enforce your brand early by applying to register your trade mark, and reflect brand rules in distributor and marketing agreements.
• People and policies: Use a tailored Employment Contract, confidentiality obligations and clear role descriptions, especially for quality/regulatory roles with TGA-facing responsibilities.
• Governance and records: Keep clean records of evidence, certificates, audits, complaints and CAPA. This makes TGA interactions and partner due diligence much easier.

Key Takeaways

• Confirm early whether your product is a medicine, device or other therapeutic good, as this drives your TGA pathway and evidence requirements.
• Every sponsor needs a solid regulatory plan: classification, evidence, GMP/conformity assessment, ARTG inclusion, compliant labels and advertising.
• Ongoing obligations matter just as much as launch: monitor safety, manage complaints, and be ready to act quickly on corrective actions or recalls.
• Selling online adds extra layers: align your website claims with approvals and use clear Website Terms and Conditions, Terms of Sale and a Privacy Policy.
• Strong contracts (Supply Agreement, manufacturing and distribution terms) and brand protection via a registered trade mark reduce risk and support growth.
• Build a compliant team and culture with tailored employment agreements and simple SOPs for quality, vigilance and TGA reporting.

If you’d like a consultation on therapeutic goods compliance in Australia, you can reach us at 1800 730 617 or team@sprintlaw.com.au for a free, no-obligations chat.